医学
血压
联合疗法
重症监护医学
疾病
药品
药物治疗
心脏病学
临床试验
内科学
药理学
作者
Pradeep Kumar Niranjan,Shiv Bahadur
出处
期刊:Cardiovascular and Hematological Disorders - Drug Targets
[Bentham Science]
日期:2023-12-01
卷期号:23 (4): 226-245
标识
DOI:10.2174/011871529x278907231120053559
摘要
Abstract: Raised blood pressure is the most common complication worldwide that may lead to atherosclerosis and ischemic heart disease. Unhealthy lifestyles, smoking, alcohol consumption, junk food, and genetic disorders are some of the causes of hypertension. To treat this condition, numerous antihypertensive medications are available, either alone or in combination, that work via various mechanisms of action. Combinational therapy provides a certain advantage over monotherapy in the sense that it acts in multi mechanism mode and minimal drug amount is required to elicit the desired therapeutic effect. Such therapy is given to patients with systolic blood pressure greater than 20 mmHg and/or diastolic blood pressure exceeding 10 mmHg beyond the normal range, as well as those suffering from severe cardiovascular disease. The selection of antihypertensive medications, such as calcium channel blockers, angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), and low-dose diuretics, hinges on their ability to manage blood pressure effectively and reduce cardiovascular disease risks. This review provides insights into the diverse monotherapy and combination therapy approaches used for elevated blood pressure management. In addition, it offers an analysis of combination therapy versus monotherapy and discusses the current status of these therapies, from researchbased findings to clinical trials.
科研通智能强力驱动
Strongly Powered by AbleSci AI